202 related articles for article (PubMed ID: 31465829)
1. Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach.
Tan HY; Ho VW; Chan YT; Zhang C; Wang N; Xia W; Feng Y
Pharmacol Res; 2020 May; 155():104415. PubMed ID: 31465829
[TBL] [Abstract][Full Text] [Related]
2. Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1.
Jiang ST; Han SY; Pang LN; Jiao YN; He XR; Li PP
Int J Mol Med; 2018 Apr; 41(4):2128-2138. PubMed ID: 29393411
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway.
Xu Z; Zhang F; Zhu Y; Liu F; Chen X; Wei L; Zhang N; Zhou Q; Zhong H; Yao C; Zhu X; Gong C; Zhu S; Zou C
J Ethnopharmacol; 2019 Apr; 234():180-188. PubMed ID: 30660711
[TBL] [Abstract][Full Text] [Related]
4. Evodiamine suppresses Notch3 signaling in lung tumorigenesis via direct binding to γ-secretases.
Yang X; Zhang Y; Huang Y; Wang Y; Qi X; Su T; Lu L
Phytomedicine; 2020 Mar; 68():153176. PubMed ID: 32045841
[TBL] [Abstract][Full Text] [Related]
5. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
6. Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. On non-small cell lung cancer based on a network pharmacology approach and experimental validation.
Zhang Y; Yao Y; Fu Y; Yuan Z; Wu X; Wang T; Hong Z; Yang Y; Wu H
J Ethnopharmacol; 2021 Oct; 278():114267. PubMed ID: 34087401
[TBL] [Abstract][Full Text] [Related]
7. Licochalcone B inhibits growth and induces apoptosis of human non-small-cell lung cancer cells by dual targeting of EGFR and MET.
Oh HN; Lee MH; Kim E; Yoon G; Chae JI; Shim JH
Phytomedicine; 2019 Oct; 63():153014. PubMed ID: 31323446
[TBL] [Abstract][Full Text] [Related]
8. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
Kang CG; Im E; Lee HJ; Lee EO
Bioorg Med Chem Lett; 2017 May; 27(9):1914-1918. PubMed ID: 28359791
[TBL] [Abstract][Full Text] [Related]
9. The repression and reciprocal interaction of DNA methyltransferase 1 and specificity protein 1 contributes to the inhibition of MET expression by the combination of Chinese herbal medicine FZKA decoction and erlotinib.
Zheng F; Zhao Y; Li X; Tang Q; Wu J; Wu W; Hann SS
J Ethnopharmacol; 2019 Jul; 239():111928. PubMed ID: 31077779
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anticancer effects of Scutellaria barbata D. Don in combination with traditional Chinese medicine components on non-small cell lung cancer cells.
Wang Q; Acharya N; Liu Z; Zhou X; Cromie M; Zhu J; Gao W
J Ethnopharmacol; 2018 May; 217():140-151. PubMed ID: 29458146
[TBL] [Abstract][Full Text] [Related]
11. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
12. ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models.
Kang HN; Kim SH; Yun MR; Kim HR; Lim SM; Kim MS; Hong KW; Kim SM; Kim H; Pyo KH; Park HJ; Han JY; Youn HA; Chang KH; Cho BC
Lung Cancer; 2016 May; 95():57-64. PubMed ID: 27040853
[TBL] [Abstract][Full Text] [Related]
13. Utilizing Bioinformatics Technology to Explore the Potential Mechanism of Danggui Buxue Decoction against NSCLC.
Yu B; Lv G; Sohail M; Li Z; Li Y; Yu M; Sun F; Xu H
Dis Markers; 2022; 2022():5296830. PubMed ID: 35256890
[TBL] [Abstract][Full Text] [Related]
14. Disclosing targets and pharmacological mechanisms of total bioflavonoids extracted from Selaginella doederleinii against non-small cell lung cancer by combination of network pharmacology and proteomics.
Xu D; Wang X; Huang D; Chen B; Lin X; Liu A; Huang J
J Ethnopharmacol; 2022 Mar; 286():114836. PubMed ID: 34793885
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
[TBL] [Abstract][Full Text] [Related]
16. Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis.
Yin Y; Wang Y; Wang C; Zhang Y; Qi A; Song J; Xu L; Yang W; Jiao L
J Ethnopharmacol; 2024 May; 326():117984. PubMed ID: 38428661
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer.
Xiao L; Lan X; Shi X; Zhao K; Wang D; Wang X; Li F; Huang H; Liu J
Cell Death Dis; 2017 May; 8(5):e2803. PubMed ID: 28518145
[TBL] [Abstract][Full Text] [Related]
19. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
Kenessey I; Kói K; Horváth O; Cserepes M; Molnár D; Izsák V; Dobos J; Hegedűs B; Tóvári J; Tímár J
Oncotarget; 2016 Nov; 7(48):79503-79514. PubMed ID: 27780929
[TBL] [Abstract][Full Text] [Related]
20. Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway.
Li W; Yu X; Tan S; Liu W; Zhou L; Liu H
Cancer Med; 2018 Jan; 7(1):208-218. PubMed ID: 29239135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
